Dr. Rebecca Gardner is a principal investigator at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute. She’s driven by a desire to revolutionize how pediatric cancer is treated and strives to reduce or eliminate the need for chemotherapy and radiation treatments.
Well on her way to achieving that goal, Gardner currently leads a cancer immunotherapy clinical trial for children with relapsed acute lymphoblastic leukemia at Seattle Children’s. The leading-edge trial uses Dr. Mike Jensen’s cellular immunotherapy research to reprogram T cells to fight pediatric cancer. The first two patients to undergo the clinical trial went into remission within two weeks of starting the trial and are still in remission today.
Along with being a world-class researcher, Gardner is an attending physician at Seattle Children’s Hospital and an assistant professor in the Department of Pediatrics at the University of Washington. She trained at the University of Maryland School of Medicine and completed her fellowship in pediatric hematology-oncology at the University of Washington School of Medicine, Seattle Children’s Hospital and Fred Hutchison Cancer Research Center.